BFCH and NEXT10 Sign Binding LOI to Create Expanded Health and Longevity Platform

BFCH's binding LOI with NEXT10 to contribute revenue-producing assets and take up to 75% ownership positions the company to accelerate its health, wellness, and longevity platform strategy.

Chicago Metrowire Staff
••Business
BFCH and NEXT10 Sign Binding LOI to Create Expanded Health and Longevity Platform

BitFrontier Capital Holdings, Inc. (OTCID: BFCH), doing business as UNLOCKD Inc., has entered into a binding Letter of Intent with NEXT10, Inc. (OTCID: NXTN) for a strategic transaction valued at $0.0004 per issued and outstanding BFCH common share. The agreement, announced via NEWMEDIAWIRE, will see NEXT10 contribute agreed revenue-producing businesses and assets to BFCH and acquire an initial noncontrolling ownership position of up to 49%, along with representation on the BFCH Board of Directors. The transaction further provides for NEXT10 to increase its ownership to approximately 75% at a subsequent Control Closing following completion of BFCH's planned audit and other agreed closing conditions. BFCH will remain a separately traded public company under the transaction structure.

The significance of this deal lies in its potential to transform BFCH from a collection of consumer brands into a broader operating platform. BFCH's current portfolio includes Ancient Extracts, EVERMIND and 1ENERGY. The NEXT10 transaction is designed to expand the platform beyond individual consumer brands and create opportunities across consumer health, wellness, longevity and human optimization. By adding revenue-producing businesses and assets, the company aims to accelerate its development into a diversified health, wellness, longevity and human optimization company capable of supporting substantially greater scale, with an ultimate objective of building toward $100 million in enterprise value. Management believes these additions can materially expand the scale and operating scope of the Company.

John P. Gorst, Chief Executive Officer of BFCH, stated, "This is a major step forward in the strategy we began implementing at BFCH last year. NEXT10 is bringing operating assets, additional resources and a broader organization behind what we are building. The transaction significantly expands the opportunities available to BFCH while allowing our team to continue executing the strategy we have established." John P. Gorst and Dr. Jordan P. Balencic will continue leading BFCH's operating and strategic development, with NEXT10 adding Board representation, revenue-producing assets and additional organizational resources.

NEXT10, through its operating platform Torreon Group, Inc., is a diversified holding and operating company focused on building value through strategic acquisitions, mergers and tangible asset development. Its businesses and investments span real estate development, affordable housing, mining, aviation, financial services and commercial enterprises in the United States and Mexico. NEXT10 provides operational and administrative resources to support the development and growth of businesses across its portfolio. Additional information about NEXT10 is available through its torreongroupinc.com website and its NEXT10, Inc. OTC Markets profile.

John B. Hayden, Chairman and Chief Executive Officer of NEXT10, commented, "We see significant opportunity in what the BFCH team has been building. This transaction gives NEXT10 a focused platform for expanding into health, wellness, longevity and human optimization while bringing additional operating assets and resources behind an existing management team and portfolio. We believe the combination creates opportunities for both organizations that would be considerably more difficult to pursue independently."

Dr. Jordan P. Balencic, Chairman and Chief Science Officer of BFCH, added, "As a physician, I see a much larger opportunity here than simply adding more consumer brands. Our vision is to build an integrated health, wellness, longevity and human optimization platform that can ultimately connect consumer products with technologies, testing, wellness services and scalable clinic concepts. NEXT10 gives us the opportunity to think and execute at a much greater scale." The broader strategy is designed to create an interconnected operating platform spanning consumer products, wellness services, longevity, human optimization, technologies and scalable operating concepts, creating opportunities for businesses within the platform to share products, distribution, customers, infrastructure and operating resources.

The parties also recognize the potential strategic value of greater alignment between the NEXT10 and BFCH shareholder communities. Following the Control Closing, they intend to evaluate lawful structures for broader shareholder participation, including a potential future distribution of a portion of NEXT10's BFCH holdings to eligible NEXT10 shareholders. No such distribution has been declared or approved. BFCH intends to complete its independent audit and, subject to applicable eligibility and reporting requirements, seek qualification for the OTCQB Venture Market. Additional details regarding the transaction and the executed binding agreement will be made available through the Company's public disclosures. The original release can be viewed on www.newmediawire.com.

Blockchain Registration

QR Code for Blockchain Registration